Return to content in this issue
Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines
Caballero ML, Quirce S
Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain
J Investig Allergol Clin Immunol 2021; Vol 31(1)
: 92-93
doi: 10.18176/jiaci.0667
Key words: Allergy, Anaphylaxis, Coronavirus, COVID-19, Immediate drug hypersensitivity reaction, Excipient, Pharmaceutical excipients, Vaccine
